Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
The main objective of the study is to observe the OXN treatment of patients with moderate to
severe non-malignant pain in daily clinical practise with respect to pain relief and bowel
function. Patients who have insufficient pain relief and/or unacceptable side effects with
the previous analgesic treatment WHO step 1 or 2 and require around-the-clock opioid therapy
can be included in the study.